Loading...

Emilie Battivelli, PhD

TitleVisiting Scientist
InstitutionUniversity of California San Francisco
DepartmentGladstone Institutes
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Kuo HH, Ahmad R, Lee GQ, Gao C, Chen HR, Ouyang Z, Szucs MJ, Kim D, Tsibris A, Chun TW, Battivelli E, Verdin E, Rosenberg ES, Carr SA, Yu XG, Lichterfeld M. Anti-apoptotic Protein BIRC5 Maintains Survival of HIV-1-Infected CD4+ T Cells. Immunity. 2018 May 15. PMID: 29802019.
      View in: PubMed
    2. Battivelli E, Dahabieh MS, Abdel-Mohsen M, Svensson JP, Tojal Da Silva I, Cohn LB, Gramatica A, Deeks S, Greene WC, Pillai SK, Verdin E. Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4+ T Cells. Elife. 2018 May 01; 7. PMID: 29714165.
      View in: PubMed
    3. Besnard E, Hakre S, Kampmann M, Lim HW, Hosmane NN, Martin A, Bassik MC, Verschueren E, Battivelli E, Chan J, Svensson JP, Gramatica A, Conrad RJ, Ott M, Greene WC, Krogan NJ, Siliciano RF, Weissman JS, Verdin E. The mTOR Complex Controls HIV Latency. Cell Host Microbe. 2016 Dec 14; 20(6):785-797. PMID: 27978436.
      View in: PubMed
    4. Vranckx LS, Demeulemeester J, Saleh S, Boll A, Vansant G, Schrijvers R, Weydert C, Battivelli E, Verdin E, Cereseto A, Christ F, Gijsbers R, Debyser Z. LEDGIN-mediated Inhibition of Integrase-LEDGF/p75 Interaction Reduces Reactivation of Residual Latent HIV. EBioMedicine. 2016 Jun; 8:248-264. PMID: 27428435; PMCID: PMC4919729.
    5. Dahabieh MS, Battivelli E, Verdin E. Understanding HIV latency: the road to an HIV cure. Annu Rev Med. 2015; 66:407-21. PMID: 25587657; PMCID: PMC4381961.
    6. Granier C, Battivelli E, LĂ©curoux C, Venet A, Lambotte O, Schmitt-Boulanger M, Delaugerre C, Molina JM, Chakrabarti LA, Clavel F, Hance AJ. Pressure from TRIM5a contributes to control of HIV-1 replication by individuals expressing protective HLA-B alleles. J Virol. 2013 Sep; 87(18):10368-80. PMID: 23864638; PMCID: PMC3753996.
    7. Battivelli E, Lecossier D, Clavel F, Hance AJ. Delaying reverse transcription does not increase sensitivity of HIV-1 to human TRIM5a. PLoS One. 2013; 8(1):e52434. PMID: 23320071; PMCID: PMC3540060.
    8. Battivelli E, Migraine J, Lecossier D, Yeni P, Clavel F, Hance AJ. Gag cytotoxic T lymphocyte escape mutations can increase sensitivity of HIV-1 to human TRIM5alpha, linking intrinsic and acquired immunity. J Virol. 2011 Nov; 85(22):11846-54. PMID: 21917976; PMCID: PMC3209307.
    9. Battivelli E, Migraine J, Lecossier D, Matsuoka S, Perez-Bercoff D, Saragosti S, Clavel F, Hance AJ. Modulation of TRIM5alpha activity in human cells by alternatively spliced TRIM5 isoforms. J Virol. 2011 Aug; 85(15):7828-35. PMID: 21632761; PMCID: PMC3147942.
    10. Battivelli E, Lecossier D, Matsuoka S, Migraine J, Clavel F, Hance AJ. Strain-specific differences in the impact of human TRIM5alpha, different TRIM5alpha alleles, and the inhibition of capsid-cyclophilin A interactions on the infectivity of HIV-1. J Virol. 2010 Nov; 84(21):11010-9. PMID: 20702630; PMCID: PMC2953162.